Breast Cancer screening guidelines were revised last year by a group of health experts (US Preventive Services Task Force or USPSTF). Based on a systematic review of published evidence, they recommended women at average risk in the age group 50 to 74 have screening mammograms every two years instead of annually. For women in the age group 40 to 49, they left it up to the woman and her doctor to determine screening based on her risk factors and harm versus benefit preferences. This change sparked a firestorm fueled by proponents of annual mammograms and those concerned that insurance companies would require copayments. The emotionally charged opposition to the recommendations may have left many women confused. As we approach Breast Cancer Awareness month, it is important to revisit this topic and review any new findings.
We’re excited to tell you that our Indiegogo campaign is underway to help women catch breast cancer early!
Will you help us reach women worldwide? We need your help to support our test kit to reach 1,000 women. This is close to our hearts in the work that we do.
We want to help women
who have dense breast tissue receive an accurate diagnosis of breast cancer as early as possible. Our test saves lives.
We need your help to donate and spread the word about our test. Our blood test, Agkura™, monitors a protein that 90% of breast cancer patients have in their bodies. The test monitors this protein and as it multiplies, breast cancer develops.
Mammograms miss 50% of breast cancers, but our test catches the development of cancer as early as 2 years in advance.
By donating to our Indiegogo campaign, you will help fund our efforts to reach more women. You can also buy a test kit for yourself or a loved one.